IOL for demanding cataract patients

Article

Oculentis has introduced the LENTIS Comfort IOL…

Oculentis has introduced the LENTIS Comfort intraocular lens (IOL) designed with demanding cataract patients in mind.

The company states that LENTIS will enable the patient to regain the best possible far vision, along with intermediate-distance vision. Some patients may become spectacle-independent in the long run.

Studies have demonstrated that the IOL can provide enhanced visuals from distances of over 60 cm and more. Overall, the LENTIS Comfort IOL is a treatment solution for everyday situations.

Booth number: S128
Website:www.oculentis.com

Please note this product may not be FDA-approved for the US.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Subscribe Now!
Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Related Content
The Agência de vigilância Sanitária (ANVISA) in Brazil. Concept image for pharmaceutical approval, Lucentis ranibizumab biosimilar ranivisio FYB201. Image credit: ©Rmcarvalhobsb – stock.adobe.com

Brazil’s ANVISA grants marketing authorization to Lucentis biosimilar FYB201 (Ranivisio, Formycon/Bioeq AG)

Lynda Charters
June 5th 2025
Article

The biopharmaceutical is the first biosimilar to ranibizumab (Genentech Inc.) approved in Brazil

Higher molar dose and its translation into clinical practice. Led by John Kitchens, MD; Joined by Peter Kaiser, MD

Higher Molar Dose and Its Translation into Clinical Practice

John Kitchens, MD;Peter Kaiser, MD
July 22nd 2024
Podcast
A bridge made from building blocks has an incomplete area. A hand reaches down with the missing block to close the gap. Concept image for age-related macular degeneration therapy and treatment article, IOL implantation and ophthalmology. Image credit: ©patpitchaya – stock.adobe.com

An implantable option bridges the gap for patients with AMD

Federico Badalà, MD
June 4th 2025
Article

Long-term benefits and vision preservation using an extended macular vision IOL

A scientist in a lab coat works at a microscope. On the right-hand side of the image, strands of sequenced DNA. Concept image for genome-wide association study in eye care, pseudodrusen and drusen, age-related macular degeneration, inherited eye ocular disease. ©Mongkolchon – stock.adobe.com

Unveiling genetic distinctions between reticular pseudodrusen and drusen

Roy Schwartz, MD, PhD
June 3rd 2025
Article

Insights from a genome-wide association study identify novel genetic loci

A small icon pinpoints a particular location on a map. Concept image for article titled "pinpointing a first-line treatment for glaucoma." Ophthalmology article, glaucoma laser treatment concept. Image credit: ©Pavlo Vakhrushev – stock.adobe.com

Pinpointing a first-line treatment for glaucoma

José María Martínez de la Casa, MD
June 3rd 2025
Article

Laser surgery is an appropriate adjunctive therapy across the continuum of glaucoma care, as well as a safe option for patients who also have cataracts and other complicating factors

A person types on a computer. An AI brain is over the screen. Concept image for artificial intelligence, therapy planning assistant system, TPS, Europe, CE mark. Image credit: ©New Africa – stock.adobe.com

EU issues CE mark for AI therapy planning assistant from deepeye Medical

Jordana Joy
June 2nd 2025
Article

The therapy planning support tool has been trained on thousands of patient cases from more than 200 retina centres throughout Europe

© 2025 MJH Life Sciences

All rights reserved.